Global Nasal Spray Live Attenuated Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Nasal spray live attenuated vaccine is a live attenuated viral vaccine administered by nasal spray for the prevention of infection against specific diseases. This vaccine injects a weakened live virus into the body through the nasal mucosal route, which activates the immune system to produce a protective immune response against the disease.
The global Nasal Spray Live Attenuated Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Nasal Spray Live Attenuated Vaccine Industry Forecast” looks at past sales and reviews total world Nasal Spray Live Attenuated Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Nasal Spray Live Attenuated Vaccine sales for 2024 through 2030. With Nasal Spray Live Attenuated Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nasal Spray Live Attenuated Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Nasal Spray Live Attenuated Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nasal Spray Live Attenuated Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nasal Spray Live Attenuated Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nasal Spray Live Attenuated Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nasal Spray Live Attenuated Vaccine.
United States market for Nasal Spray Live Attenuated Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Nasal Spray Live Attenuated Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Nasal Spray Live Attenuated Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Nasal Spray Live Attenuated Vaccine players cover AstraZeneca, Sanofi, CSL, BioDiem, SEQIRUS, INC., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Spray Live Attenuated Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Nasal Spray Live Attenuated Vaccine market?
What factors are driving Nasal Spray Live Attenuated Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nasal Spray Live Attenuated Vaccine market opportunities vary by end market size?
How does Nasal Spray Live Attenuated Vaccine break out by Type, by Application?
Nasal spray live attenuated vaccine is a live attenuated viral vaccine administered by nasal spray for the prevention of infection against specific diseases. This vaccine injects a weakened live virus into the body through the nasal mucosal route, which activates the immune system to produce a protective immune response against the disease.
The global Nasal Spray Live Attenuated Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Nasal Spray Live Attenuated Vaccine Industry Forecast” looks at past sales and reviews total world Nasal Spray Live Attenuated Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Nasal Spray Live Attenuated Vaccine sales for 2024 through 2030. With Nasal Spray Live Attenuated Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nasal Spray Live Attenuated Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Nasal Spray Live Attenuated Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nasal Spray Live Attenuated Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nasal Spray Live Attenuated Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nasal Spray Live Attenuated Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nasal Spray Live Attenuated Vaccine.
United States market for Nasal Spray Live Attenuated Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Nasal Spray Live Attenuated Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Nasal Spray Live Attenuated Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Nasal Spray Live Attenuated Vaccine players cover AstraZeneca, Sanofi, CSL, BioDiem, SEQIRUS, INC., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Spray Live Attenuated Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Trivalent Nasal Spray Live Attenuated Vaccine
- Quadrivalent Nasal Spray Live Attenuated Vaccine
- Hospitals & Clinics
- Public Health Organizations
- Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Sanofi
- CSL
- BioDiem
- SEQIRUS, INC.
- Changchun BCHT Biotechnology Co.
- Serum Institute
What is the 10-year outlook for the global Nasal Spray Live Attenuated Vaccine market?
What factors are driving Nasal Spray Live Attenuated Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nasal Spray Live Attenuated Vaccine market opportunities vary by end market size?
How does Nasal Spray Live Attenuated Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nasal Spray Live Attenuated Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Nasal Spray Live Attenuated Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Nasal Spray Live Attenuated Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Nasal Spray Live Attenuated Vaccine Segment by Type
2.2.1 Trivalent Nasal Spray Live Attenuated Vaccine
2.2.2 Quadrivalent Nasal Spray Live Attenuated Vaccine
2.3 Nasal Spray Live Attenuated Vaccine Sales by Type
2.3.1 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Nasal Spray Live Attenuated Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Nasal Spray Live Attenuated Vaccine Sale Price by Type (2019-2024)
2.4 Nasal Spray Live Attenuated Vaccine Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Public Health Organizations
2.4.3 Research Organizations
2.4.4 Others
2.5 Nasal Spray Live Attenuated Vaccine Sales by Application
2.5.1 Global Nasal Spray Live Attenuated Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Nasal Spray Live Attenuated Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Nasal Spray Live Attenuated Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Nasal Spray Live Attenuated Vaccine Breakdown Data by Company
3.1.1 Global Nasal Spray Live Attenuated Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Nasal Spray Live Attenuated Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Nasal Spray Live Attenuated Vaccine Revenue by Company (2019-2024)
3.2.2 Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Nasal Spray Live Attenuated Vaccine Sale Price by Company
3.4 Key Manufacturers Nasal Spray Live Attenuated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nasal Spray Live Attenuated Vaccine Product Location Distribution
3.4.2 Players Nasal Spray Live Attenuated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NASAL SPRAY LIVE ATTENUATED VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Nasal Spray Live Attenuated Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Nasal Spray Live Attenuated Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Nasal Spray Live Attenuated Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nasal Spray Live Attenuated Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Nasal Spray Live Attenuated Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Nasal Spray Live Attenuated Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nasal Spray Live Attenuated Vaccine Sales Growth
4.4 APAC Nasal Spray Live Attenuated Vaccine Sales Growth
4.5 Europe Nasal Spray Live Attenuated Vaccine Sales Growth
4.6 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Growth
5 AMERICAS
5.1 Americas Nasal Spray Live Attenuated Vaccine Sales by Country
5.1.1 Americas Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024)
5.1.2 Americas Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024)
5.2 Americas Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
5.3 Americas Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasal Spray Live Attenuated Vaccine Sales by Region
6.1.1 APAC Nasal Spray Live Attenuated Vaccine Sales by Region (2019-2024)
6.1.2 APAC Nasal Spray Live Attenuated Vaccine Revenue by Region (2019-2024)
6.2 APAC Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
6.3 APAC Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nasal Spray Live Attenuated Vaccine by Country
7.1.1 Europe Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024)
7.1.2 Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024)
7.2 Europe Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
7.3 Europe Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nasal Spray Live Attenuated Vaccine by Country
8.1.1 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Spray Live Attenuated Vaccine
10.3 Manufacturing Process Analysis of Nasal Spray Live Attenuated Vaccine
10.4 Industry Chain Structure of Nasal Spray Live Attenuated Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nasal Spray Live Attenuated Vaccine Distributors
11.3 Nasal Spray Live Attenuated Vaccine Customer
12 WORLD FORECAST REVIEW FOR NASAL SPRAY LIVE ATTENUATED VACCINE BY GEOGRAPHIC REGION
12.1 Global Nasal Spray Live Attenuated Vaccine Market Size Forecast by Region
12.1.1 Global Nasal Spray Live Attenuated Vaccine Forecast by Region (2025-2030)
12.1.2 Global Nasal Spray Live Attenuated Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Nasal Spray Live Attenuated Vaccine Forecast by Type (2025-2030)
12.7 Global Nasal Spray Live Attenuated Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.1.3 AstraZeneca Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.3.3 CSL Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 BioDiem
13.4.1 BioDiem Company Information
13.4.2 BioDiem Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.4.3 BioDiem Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BioDiem Main Business Overview
13.4.5 BioDiem Latest Developments
13.5 SEQIRUS, INC.
13.5.1 SEQIRUS, INC. Company Information
13.5.2 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.5.3 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 SEQIRUS, INC. Main Business Overview
13.5.5 SEQIRUS, INC. Latest Developments
13.6 Changchun BCHT Biotechnology Co.
13.6.1 Changchun BCHT Biotechnology Co. Company Information
13.6.2 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.6.3 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Changchun BCHT Biotechnology Co. Main Business Overview
13.6.5 Changchun BCHT Biotechnology Co. Latest Developments
13.7 Serum Institute
13.7.1 Serum Institute Company Information
13.7.2 Serum Institute Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.7.3 Serum Institute Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Serum Institute Main Business Overview
13.7.5 Serum Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nasal Spray Live Attenuated Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Nasal Spray Live Attenuated Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Nasal Spray Live Attenuated Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Nasal Spray Live Attenuated Vaccine Segment by Type
2.2.1 Trivalent Nasal Spray Live Attenuated Vaccine
2.2.2 Quadrivalent Nasal Spray Live Attenuated Vaccine
2.3 Nasal Spray Live Attenuated Vaccine Sales by Type
2.3.1 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Nasal Spray Live Attenuated Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Nasal Spray Live Attenuated Vaccine Sale Price by Type (2019-2024)
2.4 Nasal Spray Live Attenuated Vaccine Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Public Health Organizations
2.4.3 Research Organizations
2.4.4 Others
2.5 Nasal Spray Live Attenuated Vaccine Sales by Application
2.5.1 Global Nasal Spray Live Attenuated Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Nasal Spray Live Attenuated Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Nasal Spray Live Attenuated Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Nasal Spray Live Attenuated Vaccine Breakdown Data by Company
3.1.1 Global Nasal Spray Live Attenuated Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Nasal Spray Live Attenuated Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Nasal Spray Live Attenuated Vaccine Revenue by Company (2019-2024)
3.2.2 Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Nasal Spray Live Attenuated Vaccine Sale Price by Company
3.4 Key Manufacturers Nasal Spray Live Attenuated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nasal Spray Live Attenuated Vaccine Product Location Distribution
3.4.2 Players Nasal Spray Live Attenuated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NASAL SPRAY LIVE ATTENUATED VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Nasal Spray Live Attenuated Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Nasal Spray Live Attenuated Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Nasal Spray Live Attenuated Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nasal Spray Live Attenuated Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Nasal Spray Live Attenuated Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Nasal Spray Live Attenuated Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nasal Spray Live Attenuated Vaccine Sales Growth
4.4 APAC Nasal Spray Live Attenuated Vaccine Sales Growth
4.5 Europe Nasal Spray Live Attenuated Vaccine Sales Growth
4.6 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Growth
5 AMERICAS
5.1 Americas Nasal Spray Live Attenuated Vaccine Sales by Country
5.1.1 Americas Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024)
5.1.2 Americas Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024)
5.2 Americas Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
5.3 Americas Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasal Spray Live Attenuated Vaccine Sales by Region
6.1.1 APAC Nasal Spray Live Attenuated Vaccine Sales by Region (2019-2024)
6.1.2 APAC Nasal Spray Live Attenuated Vaccine Revenue by Region (2019-2024)
6.2 APAC Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
6.3 APAC Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nasal Spray Live Attenuated Vaccine by Country
7.1.1 Europe Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024)
7.1.2 Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024)
7.2 Europe Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
7.3 Europe Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nasal Spray Live Attenuated Vaccine by Country
8.1.1 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Spray Live Attenuated Vaccine
10.3 Manufacturing Process Analysis of Nasal Spray Live Attenuated Vaccine
10.4 Industry Chain Structure of Nasal Spray Live Attenuated Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nasal Spray Live Attenuated Vaccine Distributors
11.3 Nasal Spray Live Attenuated Vaccine Customer
12 WORLD FORECAST REVIEW FOR NASAL SPRAY LIVE ATTENUATED VACCINE BY GEOGRAPHIC REGION
12.1 Global Nasal Spray Live Attenuated Vaccine Market Size Forecast by Region
12.1.1 Global Nasal Spray Live Attenuated Vaccine Forecast by Region (2025-2030)
12.1.2 Global Nasal Spray Live Attenuated Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Nasal Spray Live Attenuated Vaccine Forecast by Type (2025-2030)
12.7 Global Nasal Spray Live Attenuated Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.1.3 AstraZeneca Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.3.3 CSL Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 BioDiem
13.4.1 BioDiem Company Information
13.4.2 BioDiem Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.4.3 BioDiem Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BioDiem Main Business Overview
13.4.5 BioDiem Latest Developments
13.5 SEQIRUS, INC.
13.5.1 SEQIRUS, INC. Company Information
13.5.2 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.5.3 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 SEQIRUS, INC. Main Business Overview
13.5.5 SEQIRUS, INC. Latest Developments
13.6 Changchun BCHT Biotechnology Co.
13.6.1 Changchun BCHT Biotechnology Co. Company Information
13.6.2 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.6.3 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Changchun BCHT Biotechnology Co. Main Business Overview
13.6.5 Changchun BCHT Biotechnology Co. Latest Developments
13.7 Serum Institute
13.7.1 Serum Institute Company Information
13.7.2 Serum Institute Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
13.7.3 Serum Institute Nasal Spray Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Serum Institute Main Business Overview
13.7.5 Serum Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nasal Spray Live Attenuated Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nasal Spray Live Attenuated Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Trivalent Nasal Spray Live Attenuated Vaccine
Table 4. Major Players of Quadrivalent Nasal Spray Live Attenuated Vaccine
Table 5. Global Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 6. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Nasal Spray Live Attenuated Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Nasal Spray Live Attenuated Vaccine Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Nasal Spray Live Attenuated Vaccine Sale by Application (2019-2024) & (K Dose)
Table 11. Global Nasal Spray Live Attenuated Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global Nasal Spray Live Attenuated Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Nasal Spray Live Attenuated Vaccine Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Nasal Spray Live Attenuated Vaccine Sales by Company (2019-2024) & (K Dose)
Table 16. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Nasal Spray Live Attenuated Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Nasal Spray Live Attenuated Vaccine Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Nasal Spray Live Attenuated Vaccine Producing Area Distribution and Sales Area
Table 21. Players Nasal Spray Live Attenuated Vaccine Products Offered
Table 22. Nasal Spray Live Attenuated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nasal Spray Live Attenuated Vaccine Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Nasal Spray Live Attenuated Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Nasal Spray Live Attenuated Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Nasal Spray Live Attenuated Vaccine Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Nasal Spray Live Attenuated Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Nasal Spray Live Attenuated Vaccine Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC Nasal Spray Live Attenuated Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Nasal Spray Live Attenuated Vaccine
Table 52. Key Market Challenges & Risks of Nasal Spray Live Attenuated Vaccine
Table 53. Key Industry Trends of Nasal Spray Live Attenuated Vaccine
Table 54. Nasal Spray Live Attenuated Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nasal Spray Live Attenuated Vaccine Distributors List
Table 57. Nasal Spray Live Attenuated Vaccine Customer List
Table 58. Global Nasal Spray Live Attenuated Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Nasal Spray Live Attenuated Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Nasal Spray Live Attenuated Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Nasal Spray Live Attenuated Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Nasal Spray Live Attenuated Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Nasal Spray Live Attenuated Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Nasal Spray Live Attenuated Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Nasal Spray Live Attenuated Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Nasal Spray Live Attenuated Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Nasal Spray Live Attenuated Vaccine Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Nasal Spray Live Attenuated Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Nasal Spray Live Attenuated Vaccine Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Nasal Spray Live Attenuated Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. AstraZeneca Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. AstraZeneca Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 74. AstraZeneca Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Latest Developments
Table 77. Sanofi Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 79. Sanofi Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. CSL Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. CSL Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 84. CSL Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. CSL Main Business
Table 86. CSL Latest Developments
Table 87. BioDiem Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. BioDiem Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 89. BioDiem Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. BioDiem Main Business
Table 91. BioDiem Latest Developments
Table 92. SEQIRUS, INC. Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 94. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. SEQIRUS, INC. Main Business
Table 96. SEQIRUS, INC. Latest Developments
Table 97. Changchun BCHT Biotechnology Co. Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 99. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Changchun BCHT Biotechnology Co. Main Business
Table 101. Changchun BCHT Biotechnology Co. Latest Developments
Table 102. Serum Institute Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Serum Institute Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 104. Serum Institute Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Serum Institute Main Business
Table 106. Serum Institute Latest Developments
Table 1. Nasal Spray Live Attenuated Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nasal Spray Live Attenuated Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Trivalent Nasal Spray Live Attenuated Vaccine
Table 4. Major Players of Quadrivalent Nasal Spray Live Attenuated Vaccine
Table 5. Global Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 6. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Nasal Spray Live Attenuated Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Nasal Spray Live Attenuated Vaccine Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Nasal Spray Live Attenuated Vaccine Sale by Application (2019-2024) & (K Dose)
Table 11. Global Nasal Spray Live Attenuated Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global Nasal Spray Live Attenuated Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Nasal Spray Live Attenuated Vaccine Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Nasal Spray Live Attenuated Vaccine Sales by Company (2019-2024) & (K Dose)
Table 16. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Nasal Spray Live Attenuated Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Nasal Spray Live Attenuated Vaccine Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Nasal Spray Live Attenuated Vaccine Producing Area Distribution and Sales Area
Table 21. Players Nasal Spray Live Attenuated Vaccine Products Offered
Table 22. Nasal Spray Live Attenuated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nasal Spray Live Attenuated Vaccine Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Nasal Spray Live Attenuated Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Nasal Spray Live Attenuated Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Nasal Spray Live Attenuated Vaccine Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Nasal Spray Live Attenuated Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Nasal Spray Live Attenuated Vaccine Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC Nasal Spray Live Attenuated Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Nasal Spray Live Attenuated Vaccine
Table 52. Key Market Challenges & Risks of Nasal Spray Live Attenuated Vaccine
Table 53. Key Industry Trends of Nasal Spray Live Attenuated Vaccine
Table 54. Nasal Spray Live Attenuated Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nasal Spray Live Attenuated Vaccine Distributors List
Table 57. Nasal Spray Live Attenuated Vaccine Customer List
Table 58. Global Nasal Spray Live Attenuated Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Nasal Spray Live Attenuated Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Nasal Spray Live Attenuated Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Nasal Spray Live Attenuated Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Nasal Spray Live Attenuated Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Nasal Spray Live Attenuated Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Nasal Spray Live Attenuated Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Nasal Spray Live Attenuated Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Nasal Spray Live Attenuated Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Nasal Spray Live Attenuated Vaccine Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Nasal Spray Live Attenuated Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Nasal Spray Live Attenuated Vaccine Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Nasal Spray Live Attenuated Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. AstraZeneca Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. AstraZeneca Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 74. AstraZeneca Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Latest Developments
Table 77. Sanofi Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 79. Sanofi Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. CSL Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. CSL Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 84. CSL Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. CSL Main Business
Table 86. CSL Latest Developments
Table 87. BioDiem Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. BioDiem Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 89. BioDiem Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. BioDiem Main Business
Table 91. BioDiem Latest Developments
Table 92. SEQIRUS, INC. Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 94. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. SEQIRUS, INC. Main Business
Table 96. SEQIRUS, INC. Latest Developments
Table 97. Changchun BCHT Biotechnology Co. Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 99. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Changchun BCHT Biotechnology Co. Main Business
Table 101. Changchun BCHT Biotechnology Co. Latest Developments
Table 102. Serum Institute Basic Information, Nasal Spray Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Serum Institute Nasal Spray Live Attenuated Vaccine Product Portfolios and Specifications
Table 104. Serum Institute Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Serum Institute Main Business
Table 106. Serum Institute Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nasal Spray Live Attenuated Vaccine
Figure 2. Nasal Spray Live Attenuated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nasal Spray Live Attenuated Vaccine Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Nasal Spray Live Attenuated Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Nasal Spray Live Attenuated Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Nasal Spray Live Attenuated Vaccine Sales Market Share by Country/Region (2023)
Figure 10. Nasal Spray Live Attenuated Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Trivalent Nasal Spray Live Attenuated Vaccine
Figure 12. Product Picture of Quadrivalent Nasal Spray Live Attenuated Vaccine
Figure 13. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type in 2023
Figure 14. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Nasal Spray Live Attenuated Vaccine Consumed in Hospitals & Clinics
Figure 16. Global Nasal Spray Live Attenuated Vaccine Market: Hospitals & Clinics (2019-2024) & (K Dose)
Figure 17. Nasal Spray Live Attenuated Vaccine Consumed in Public Health Organizations
Figure 18. Global Nasal Spray Live Attenuated Vaccine Market: Public Health Organizations (2019-2024) & (K Dose)
Figure 19. Nasal Spray Live Attenuated Vaccine Consumed in Research Organizations
Figure 20. Global Nasal Spray Live Attenuated Vaccine Market: Research Organizations (2019-2024) & (K Dose)
Figure 21. Nasal Spray Live Attenuated Vaccine Consumed in Others
Figure 22. Global Nasal Spray Live Attenuated Vaccine Market: Others (2019-2024) & (K Dose)
Figure 23. Global Nasal Spray Live Attenuated Vaccine Sale Market Share by Application (2023)
Figure 24. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application in 2023
Figure 25. Nasal Spray Live Attenuated Vaccine Sales by Company in 2023 (K Dose)
Figure 26. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Company in 2023
Figure 27. Nasal Spray Live Attenuated Vaccine Revenue by Company in 2023 ($ millions)
Figure 28. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Company in 2023
Figure 29. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Nasal Spray Live Attenuated Vaccine Sales 2019-2024 (K Dose)
Figure 32. Americas Nasal Spray Live Attenuated Vaccine Revenue 2019-2024 ($ millions)
Figure 33. APAC Nasal Spray Live Attenuated Vaccine Sales 2019-2024 (K Dose)
Figure 34. APAC Nasal Spray Live Attenuated Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Europe Nasal Spray Live Attenuated Vaccine Sales 2019-2024 (K Dose)
Figure 36. Europe Nasal Spray Live Attenuated Vaccine Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales 2019-2024 (K Dose)
Figure 38. Middle East & Africa Nasal Spray Live Attenuated Vaccine Revenue 2019-2024 ($ millions)
Figure 39. Americas Nasal Spray Live Attenuated Vaccine Sales Market Share by Country in 2023
Figure 40. Americas Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2024)
Figure 41. Americas Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Figure 42. Americas Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Figure 43. United States Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Nasal Spray Live Attenuated Vaccine Sales Market Share by Region in 2023
Figure 48. APAC Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2019-2024)
Figure 49. APAC Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Figure 50. APAC Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Figure 51. China Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 55. India Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Country in 2023
Figure 59. Europe Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2024)
Figure 60. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Figure 61. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Figure 62. Germany Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. France Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Figure 70. Egypt Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Nasal Spray Live Attenuated Vaccine in 2023
Figure 76. Manufacturing Process Analysis of Nasal Spray Live Attenuated Vaccine
Figure 77. Industry Chain Structure of Nasal Spray Live Attenuated Vaccine
Figure 78. Channels of Distribution
Figure 79. Global Nasal Spray Live Attenuated Vaccine Sales Market Forecast by Region (2025-2030)
Figure 80. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Nasal Spray Live Attenuated Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Nasal Spray Live Attenuated Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Nasal Spray Live Attenuated Vaccine
Figure 2. Nasal Spray Live Attenuated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nasal Spray Live Attenuated Vaccine Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Nasal Spray Live Attenuated Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Nasal Spray Live Attenuated Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Nasal Spray Live Attenuated Vaccine Sales Market Share by Country/Region (2023)
Figure 10. Nasal Spray Live Attenuated Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Trivalent Nasal Spray Live Attenuated Vaccine
Figure 12. Product Picture of Quadrivalent Nasal Spray Live Attenuated Vaccine
Figure 13. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type in 2023
Figure 14. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Nasal Spray Live Attenuated Vaccine Consumed in Hospitals & Clinics
Figure 16. Global Nasal Spray Live Attenuated Vaccine Market: Hospitals & Clinics (2019-2024) & (K Dose)
Figure 17. Nasal Spray Live Attenuated Vaccine Consumed in Public Health Organizations
Figure 18. Global Nasal Spray Live Attenuated Vaccine Market: Public Health Organizations (2019-2024) & (K Dose)
Figure 19. Nasal Spray Live Attenuated Vaccine Consumed in Research Organizations
Figure 20. Global Nasal Spray Live Attenuated Vaccine Market: Research Organizations (2019-2024) & (K Dose)
Figure 21. Nasal Spray Live Attenuated Vaccine Consumed in Others
Figure 22. Global Nasal Spray Live Attenuated Vaccine Market: Others (2019-2024) & (K Dose)
Figure 23. Global Nasal Spray Live Attenuated Vaccine Sale Market Share by Application (2023)
Figure 24. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application in 2023
Figure 25. Nasal Spray Live Attenuated Vaccine Sales by Company in 2023 (K Dose)
Figure 26. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Company in 2023
Figure 27. Nasal Spray Live Attenuated Vaccine Revenue by Company in 2023 ($ millions)
Figure 28. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Company in 2023
Figure 29. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Nasal Spray Live Attenuated Vaccine Sales 2019-2024 (K Dose)
Figure 32. Americas Nasal Spray Live Attenuated Vaccine Revenue 2019-2024 ($ millions)
Figure 33. APAC Nasal Spray Live Attenuated Vaccine Sales 2019-2024 (K Dose)
Figure 34. APAC Nasal Spray Live Attenuated Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Europe Nasal Spray Live Attenuated Vaccine Sales 2019-2024 (K Dose)
Figure 36. Europe Nasal Spray Live Attenuated Vaccine Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales 2019-2024 (K Dose)
Figure 38. Middle East & Africa Nasal Spray Live Attenuated Vaccine Revenue 2019-2024 ($ millions)
Figure 39. Americas Nasal Spray Live Attenuated Vaccine Sales Market Share by Country in 2023
Figure 40. Americas Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2024)
Figure 41. Americas Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Figure 42. Americas Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Figure 43. United States Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Nasal Spray Live Attenuated Vaccine Sales Market Share by Region in 2023
Figure 48. APAC Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2019-2024)
Figure 49. APAC Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Figure 50. APAC Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Figure 51. China Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 55. India Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Country in 2023
Figure 59. Europe Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2024)
Figure 60. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Figure 61. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Figure 62. Germany Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. France Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Figure 70. Egypt Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Nasal Spray Live Attenuated Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Nasal Spray Live Attenuated Vaccine in 2023
Figure 76. Manufacturing Process Analysis of Nasal Spray Live Attenuated Vaccine
Figure 77. Industry Chain Structure of Nasal Spray Live Attenuated Vaccine
Figure 78. Channels of Distribution
Figure 79. Global Nasal Spray Live Attenuated Vaccine Sales Market Forecast by Region (2025-2030)
Figure 80. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Nasal Spray Live Attenuated Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Nasal Spray Live Attenuated Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share Forecast by Application (2025-2030)
